AEterna Zentaris, Inc.

Cetrorelix development to continue in benign prostate hyperplasia in Japan

Published in Healthcare Mergers, Acquisitions and Ventures Week, April 23rd, 2005

AEterna Zentaris, Inc., (AEZ; AEZS) announced the decision of its Japanese partners Shionogi & Co., Ltd., and Nippon Kayaku Co., Ltd., to push ahead with the development of cetrorelix, a luteinizing hormone-releasing hormone (LHRH) antagonist, in the benign prostate hyperplasia (BPH) indication.

The decision comes on the heels of the earlier announcement by Solvay Pharmaceuticals, the company's worldwide (ex-Japan) exclusive development and marketing partner for cetrorelix, to conduct its upcoming phase III development in endometriosis as a primary indication.

Cetrorelix, AEterna Zentaris' lead drug in the class of LHRH antagonists, has successfully...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week

Source: Healthcare Mergers, Acquisitions and Ventures Week (2005-04-23)

More Articles from Healthcare Mergers, Acquisitions and Ventures Week

Abgenix, Inc.
Antibody product maker files resale registration statement
AmeriPath, Inc.
Cancer diagnostics company reports net loss of $1.6M
American Academy of Actuaries
Social Security, Medicare reports show no financial change, actuaries conclude
American Bio Medica Corporation
Biotech company reports slight increase in net sales
American HomePatient, Inc.
Home healthcare company reports 3.1% decrease in revenue
Animas Corporation
Cygnus asset purchase consummated
More from this issue of Healthcare Mergers, Acquisitions and Ventures Week

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry